Corrigendum to “mFOLFOX6 versus mFOLFOX6 + aflibercept as neoadjuvant treatment in MRI-defined T3-rectal cancer: a randomized phase-II-trial of the German Rectal Cancer Study Group (CAO/ARO/AIO 0214) and the ABCSG (R-06)”$d[ESMO Open 9 (2024) 103703] : corrigendum
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) Editorial |
| Language: | English |
| Published: |
February 2025
|
| In: |
ESMO open
Year: 2025, Volume: 10, Issue: 2, Pages: 1-1 |
| ISSN: | 2059-7029 |
| DOI: | 10.1016/j.esmoop.2024.104095 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.esmoop.2024.104095 Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S2059702924018660 |
| Author Notes: | R.-D. Hofheinz, F. Herrle, T. Dechow, L.F. von Weikersthal, M. Welslau, S. Lettmaier, C. Burkart, S. Kubicka, L. Kochen, K. Merx, K. Krause, M. Ebert, C. Rödel, E. Fokas, M. Ghadimi, C. Reissfelder & T. Gaiser |
| Item Description: | Online verfügbar: 16. Dezember 2024, Artikelversion: 20. Februar 2025 Gesehen am 14.07.2025 |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 2059-7029 |
| DOI: | 10.1016/j.esmoop.2024.104095 |